Clinical Trial of Safety and Efficacy of IHN-A21 for the Prevention of Nosocomial Staphylococcal Bloodstream Infection in Premature Infants

Journal of Pediatrics

Volumn 151, Issue 3, 2007, Pages

  DeJonge, Mitchell ^a   Burchfield, David ^b   Bloom, Barry ^c   Duenas, Maria ^d   Walker, Whit ^e   Polak, Mark ^f   Jung, Elizabeth ^g   Millard, Dietra ^h   Schelonka, Robert ⁱ   Eyal, Fabien ^j   Morris, Amy ^k   Kapik, Barry ^k   Roberson, Destrey ^k   Kesler, Karen ^l   Patti, Joe ^k   Hetherington, Seth ^k  

^a HELEN DEVOS CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c WESLEY MEDICAL CENTER   (United States)

^d ST JOHN HOSPITAL AND MEDICAL CENTER   (United States)

^e GREENVILLE HOSPITAL SYSTEM   (United States)

^f WEST VIRGINIA UNIVERSITY HOSPITALS   (United States)

^g ST JOHN S MERCY MEDICAL CENTER   (United States)

^h EVANSTON HOSPITAL   (United States)

ⁱ UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^j UNIVERSITY OF SOUTH ALABAMA   (United States)

^k Inhibitex Inc   (United States)

^l RHO INC   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; ANTIFUNGAL AGENT; IMMUNOGLOBULIN; IMMUNOGLOBULIN ANTIBODY; INH A21; PLACEBO; SODIUM CHLORIDE; UNCLASSIFIED DRUG; VERONATE;

ABSENCE OF SIDE EFFECTS; AIR EMBOLISM; ANTIBODY TITER; ARTICLE; BIRTH WEIGHT; BLOOD FLOW; BRADYCARDIA; CANDIDA; CANDIDEMIA; CLINICAL TRIAL; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIGESTIVE SYSTEM PERFORATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INFUSION; DRUG SAFETY; FEMALE; HOSPITAL INFECTION; HUMAN; HYDROCEPHALUS; INFANT; INTENSIVE CARE UNIT; INTESTINE PERFORATION; LOW BIRTH WEIGHT; LUNG HEMORRHAGE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; NEWBORN; NEWBORN INTENSIVE CARE; PNEUMOTHORAX; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETROLENTAL FIBROPLASIA; SEPSIS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION; STATISTICAL SIGNIFICANCE; TREATMENT FAILURE;

EID: 34548048636     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2007.04.060     Document Type: Article

References (38)

1. Martin J.A., Hamilton B.E., Ventura S.J., Menacker F., and Park M.M. Births: final data for 2000. Natl Vital Stat Rep 50 (2002) 1-101
2. Fanaroff A.A., Hack M., and Walsh M.C. The NICHD neonatal research network: changes in practice and outcomes during the first 15 years. Semin Perinatol 27 (2003) 281-287
3. Fanaroff A.A., Korones S.B., Wright L.L., Verter J., Poland R.L., Bauer C.R., et al. Incidence, presenting features, risk factors and significance of late onset septicemia in very low birth weight infants. The National Institute of Child Health and Human Development Neonatal Research Network. Pediatr Infect Dis J 17 (1998) 593-598
4. Stoll B.J., Gordon T., Korones S.B., Shankaran S., Tyson J.E., Bauer C.R., et al. Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 129 (1996) 63-71
5. Stoll B.J., Hansen N., Fanaroff A.A., Wright L.L., Carlo W.A., Ehrenkranz R.A., et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 110 (2002) 285-291
6. Stoll B.J., Hansen N.I., Adams-Chapman I., Fanaroff A.A., Hintz S.R., Vohr B., et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 292 (2004) 2357-2365
7. Fanaroff A.A., Korones S.B., Wright L.L., Wright E.C., Poland R.L., Bauer C.B., et al. A controlled trial of intravenous immune globulin to reduce nosocomial infections in very-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med 330 (1994) 1107-1113
8. Hill H.R. Additional confirmation of the lack of effect of intravenous immunoglobulin in the prevention of neonatal infection. J Pediatr 137 (2000) 595-597
9. Ohlsson A., and Lacy J.B. Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants. Cochrane Database Syst Rev (2004) CD000361
10. Baker C.J., Melish M.E., Hall R.T., Casto D.T., Vasan U., and Givner L.B. Intravenous immune globulin for the prevention of nosocomial infection in low-birth-weight neonates. The Multicenter Group for the Study of Immune Globulin in Neonates. N Engl J Med 327 (1992) 213-219
11. Healy C.M., Palazzi D.L., Edwards M.S., Campbell J.R., and Baker C.J. Features of invasive staphylococcal disease in neonates. Pediatrics 114 (2004) 953-961
12. Bloom B., Schelonka R., Kueser T., Walker W., Jung E., Kaufman D., et al. Multicenter study to assess safety and efficacy of INH-A21, a donor-selected human staphylococcal immunoglobulin, for prevention of nosocomial infections in very low birth weight infants. Pediatr Infect Dis J 24 (2005) 858-866
13. Vernachio J., Bayer A.S., Le T., Chai Y.L., Prater B., Schneider A., et al. Anti-clumping factor A immunoglobulin reduces the duration of methicillin-resistant Staphylococcus aureus bacteremia in an experimental model of infective endocarditis. Antimicrob Agents Chemother 47 (2003) 3400-3406
14. Patti J.M., Allen B.L., McGavin M.J., and Hook M. MSCRAMM-mediated adherence of microorganisms to host tissues. Annu Rev Microbiol 48 (1994) 585-617
15. Höök M, Patti JM, McGavin M, Gurusiddappa S, Lindgren PE, Jönsson K, et al. MSCRAMMs-microbial recognition systems for extracellular matrix molecules. In: Wadström T, Holder, I, and Kronvall, G, eds Molecular Pathogenesis of Surgical Infections. Stuttgart: Gustav Fischer Verlag; 1994137-44.
16. Capparelli E.V., Bloom B.T., Kueser T.J., Oelberg D.G., Bifano E.M., White R.D., et al. Multicenter study to determine antibody concentrations and assess the safety of administration of INH-A21, a donor-selected human staphylococcal immune globulin, in low-birth-weight infants. Antimicrob Agents Chemother 49 (2005) 4121-4127
17. Krediet T.G., Beurskens F.J., van Dijk H., Gerards L.J., and Fleer A. Antibody responses and opsonic activity in sera of preterm neonates with coagulase-negative staphylococcal septicemia and the effect of the administration of fresh frozen plasma. Pediatr Res 43 (1998) 645-651
18. Fischer G.W., Cieslak T.J., Wilson S.R., Weisman L.E., and Hemming V.G. Opsonic antibodies to Staphylococcus epidermidis: in vitro and in vivo studies using human intravenous immune globulin. J Infect Dis 169 (1994) 324-329
19. Etzioni A., Obedeanu N., Blazer S., Benderly A., and Merzbach D. Effect of an intravenous gammaglobulin preparation on the opsonophagocytic activity of preterm serum against coagulase-negative staphylococci. Acta Paediatr Scand 79 (1990) 156-161
20. Clark L.A., and Easmon C.S. Opsonic requirements of Staphylococcus epidermidis. J Med Microbiol 22 (1986) 1-7
21. Christensen R.D., Hardman T., Thornton J., and Hill H.R. A randomized, double-blind, placebo-controlled investigation of the safety of intravenous immune globulin administration to preterm neonates. J Perinatol 9 (1989) 126-130
22. Fischer G.W. Use of intravenous immune globulin in newborn infants. Clin Exp Immunol 97 suppl 1 (1994) 73-77
23. Jenson H.B., and Pollock B.H. Meta-analyses of the effectiveness of intravenous immune globulin for prevention and treatment of neonatal sepsis. Pediatrics 99 (1997) E2. http://www.pediatrics.org/cgi/content/Full/99/z/e2 http://www.pediatrics.org/cgi/content/full/99/z/e2.
24. Vernachio J.H., Bayer A.S., Ames B., Bryant D., Prater B.D., Syribeys P.J., et al. Human immunoglobulin G recognizing fibrinogen-binding surface proteins is protective against both Staphylococcus aureus and Staphylococcus epidermidis infections in vivo. Antimicrob Agents Chemother 50 (2006) 511-518
25. Lin F.Y., Weisman L.E., Azimi P.H., Philips III J.B., Clark P., Regan J., et al. Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen. J Infect Dis 190 (2004) 928-934
26. Shinefield H., Black S., Fattom A., Horwith G., Rasgon S., Ordonez J., et al. Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. N Engl J Med 346 (2002) 491-496
27. Ahsan N., Wiegand L.A., Abendroth C.S., and Manning E.C. Acute renal failure following immunoglobulin therapy. Am J Nephrol 16 (1996) 532-536
28. Brannagan III T.H., Nagle K.J., Lange D.J., and Rowland L.P. Complications of intravenous immune globulin treatment in neurologic disease. Neurology 47 (1996) 674-677
29. Cantu T.G., Hoehn-Saric E.W., Burgess K.M., Racusen L., and Scheel P.J. Acute renal failure associated with immunoglobulin therapy. Am J Kidney Dis 25 (1995) 228-234
30. Michail S., Nakopoulou L., Stavrianopoulos I., Stamatiadis D., Avdikou K., Vaiopoulos G., et al. Acute renal failure associated with immunoglobulin administration. Nephrol Dial Transplant 12 (1997) 1497-1499
31. Sati H.I., Ahya R., and Watson H.G. Incidence and associations of acute renal failure complicating high-dose intravenous immunoglobulin therapy. Br J Haematol 113 (2001) 556-557
32. Cayco A.V., Perazella M.A., and Hayslett J.P. Renal insufficiency after intravenous immune globulin therapy: a report of two cases and an analysis of the literature. J Am Soc Nephrol 8 (1997) 1788-1794
33. Hansen-Schmidt S., Silomon J., and Keller F. Osmotic nephrosis due to high-dose immunoglobulin therapy containing sucrose (but not with glycine) in a patient with immunoglobulin A nephritis. Am J Kidney Dis 28 (1996) 451-453
34. Casteels-Van Daele M., Wijndaele L., Hanninck K., and Gillis P. Intravenous immune globulin and acute aseptic meningitis. N Engl J Med 323 (1990) 614-615
35. Scribner C.L., Kapit R.M., Phillips E.T., and Rickles N.M. Aseptic meningitis and intravenous immunoglobulin therapy. Ann Intern Med 121 (1994) 305-306
36. Sekul E.A., Cupler E.J., and Dalakas M.C. Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: frequency and risk factors. Ann Intern Med 121 (1994) 259-262
37. Lassiter H.A., Bibb K.W., Bertolone S.J., Patel C.C., and Stroncek D.F. Neonatal immune neutropenia following the administration of intravenous immune globulin. Am J Pediatr Hematol Oncol 15 (1993) 120-123
38. Gladstone I.M., Ehrenkranz R.A., Edberg S.C., and Baltimore R.S. A ten-year review of neonatal sepsis and comparison with the previous fifty-year experience. Pediatr Infect Dis J 9 (1990) 819-825